COMP <GO>
JAN vs BRK-B // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Janus Living Inc. Class A-1 (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: JAN 4
— BRK-B 9
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: BRK-B
LAST: $28.52 (0.00%) • MKT CAP: $8.85B
options-implied-move
6.60%
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
options-implied-move
3.55%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JAN VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JAN | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.40% | 11.47% | -11.07 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 9.7x | +85.32 | BRK-B | /valuation <GO> |
| Free Cash Flow Yield | 1.24% | 2.09% | -0.85 | BRK-B | /fcf-yield <GO> |
| Operating Margin | 1.30% | 27.80% | -26.50 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | 1.10% | 22.30% | -21.20 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 6.20% | 3.93% | +2.27 | JAN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.85 | 2.85 | +3.00 | JAN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | JAN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.60% | 3.55% | +3.05 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.1 | 66.8 | -19.73 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.61 | +0.30 | JAN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 24.3x | +115.66 | BRK-B | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.85B | $1.16T | -$1.15T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JAN REV | BRK-B REV | JAN GROSS % | BRK-B GROSS % | JAN FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $604.0M | $371.44B | 44.0% | — | $109.6M | $25.04B |
| FY 2024 | $568.5M | $371.43B | 44.0% | — | $103.0M | $11.62B |
| FY 2023 | — | $364.48B | — | — | — | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JAN // BETA 0.91
BRK-B // BETA 0.61